Krystal Biotech, Inc. (BIT:1KRYS)
Italy
· Delayed Price · Currency is EUR 119.35
-4.60 (-3.71%)
At close: May 13, 2025
Krystal Biotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Cash & Equivalents | 308.77 | 344.87 | 358.33 | 161.9 | 341.25 | 268.27 | Upgrade
|
| Short-Term Investments | 308.08 | 252.65 | 173.85 | 217.27 | 96.85 | 2.99 | Upgrade
|
| Cash & Short-Term Investments | 616.85 | 597.52 | 532.18 | 379.17 | 438.1 | 271.26 | Upgrade
|
| Cash Growth | 14.60% | 12.28% | 40.35% | -13.45% | 61.50% | 40.05% | Upgrade
|
| Receivables | 103.26 | 104.75 | 42.04 | - | - | - | Upgrade
|
| Inventory | 29.94 | 26.51 | 6.99 | - | - | - | Upgrade
|
| Prepaid Expenses | 16.75 | 13.27 | 6.71 | 4.61 | 4.17 | 3.8 | Upgrade
|
| Total Current Assets | 766.8 | 742.05 | 587.91 | 383.78 | 442.27 | 275.06 | Upgrade
|
| Property, Plant & Equipment | 158.93 | 161.45 | 168.23 | 169.73 | 119.58 | 34.17 | Upgrade
|
| Long-Term Investments | 148.47 | 152.11 | 61.95 | 4.62 | 64.37 | - | Upgrade
|
| Other Long-Term Assets | 0.22 | 0.23 | 0.26 | 0.32 | 0.07 | 1.61 | Upgrade
|
| Total Assets | 1,074 | 1,056 | 818.36 | 558.45 | 626.3 | 310.84 | Upgrade
|
| Accounts Payable | 2.67 | 4.99 | 4.13 | 3.98 | 8.4 | 2.11 | Upgrade
|
| Accrued Expenses | 59.29 | 52.78 | 18.15 | 11.54 | 6.52 | 3.99 | Upgrade
|
| Current Portion of Leases | 1.36 | 1.22 | 1.47 | 1.56 | 1.04 | 0.64 | Upgrade
|
| Current Income Taxes Payable | 11.43 | 4.29 | 1.96 | 0.04 | 0.08 | 0.04 | Upgrade
|
| Other Current Liabilities | 4.73 | 38.73 | 7.38 | 11.72 | 9.69 | 8.68 | Upgrade
|
| Total Current Liabilities | 79.49 | 102 | 33.09 | 28.85 | 25.74 | 15.45 | Upgrade
|
| Long-Term Leases | 8.3 | 6.04 | 6.62 | 7.37 | 6.98 | 3.31 | Upgrade
|
| Other Long-Term Liabilities | 1.95 | 1.42 | - | - | - | - | Upgrade
|
| Total Liabilities | 89.74 | 109.46 | 39.71 | 36.22 | 32.72 | 18.76 | Upgrade
|
| Additional Paid-In Capital | 1,129 | 1,127 | 1,048 | 803.72 | 734.52 | 363.29 | Upgrade
|
| Retained Earnings | -144.94 | -180.67 | -269.83 | -280.76 | -140.78 | -71.21 | Upgrade
|
| Comprehensive Income & Other | 0.39 | -0.19 | 0.64 | -0.73 | -0.16 | 0.01 | Upgrade
|
| Total Common Equity | 984.67 | 946.38 | 778.64 | 522.23 | 593.58 | 292.08 | Upgrade
|
| Shareholders' Equity | 984.67 | 946.38 | 778.64 | 522.23 | 593.58 | 292.08 | Upgrade
|
| Total Liabilities & Equity | 1,074 | 1,056 | 818.36 | 558.45 | 626.3 | 310.84 | Upgrade
|
| Total Debt | 9.66 | 7.26 | 8.09 | 8.93 | 8.02 | 3.95 | Upgrade
|
| Net Cash (Debt) | 755.66 | 742.37 | 586.04 | 374.86 | 494.44 | 267.32 | Upgrade
|
| Net Cash Growth | 23.00% | 26.68% | 56.34% | -24.19% | 84.97% | 40.38% | Upgrade
|
| Net Cash Per Share | 25.29 | 24.96 | 21.12 | 14.70 | 22.28 | 14.23 | Upgrade
|
| Filing Date Shares Outstanding | 28.9 | 28.81 | 28.29 | 25.76 | 25.21 | 22.19 | Upgrade
|
| Total Common Shares Outstanding | 28.9 | 28.79 | 28.24 | 25.76 | 25.21 | 19.71 | Upgrade
|
| Working Capital | 687.31 | 640.05 | 554.82 | 354.93 | 416.53 | 259.61 | Upgrade
|
| Book Value Per Share | 34.07 | 32.87 | 27.58 | 20.27 | 23.55 | 14.82 | Upgrade
|
| Tangible Book Value | 984.67 | 946.38 | 778.64 | 522.23 | 593.58 | 292.08 | Upgrade
|
| Tangible Book Value Per Share | 34.07 | 32.87 | 27.58 | 20.27 | 23.55 | 14.82 | Upgrade
|
| Buildings | 109.14 | 111.44 | 111.18 | - | - | - | Upgrade
|
| Machinery | 35.64 | 34.19 | 30.49 | 12.93 | 6.51 | 5.58 | Upgrade
|
| Construction In Progress | 4.87 | 5.78 | 7.29 | 131.33 | 104.34 | 23.03 | Upgrade
|
| Leasehold Improvements | 25.69 | 25.67 | 25.07 | 24.22 | 5.72 | 4.63 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.